Hematologic malignancies Clinical Trials
Conditions / Hematologic malignancies
Delta Trials tracks 4 clinical trials for Hematologic malignancies in its publicly accessible dataset. Among the listed trials, 3 open for participant enrollment and 0 trials have reached completion. This research is carried out at 623 clinical sites around the world. An additional 1 trial have active registrations outside the recruiting and completed categories. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
4
Total Trials
3
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
623
Study Locations
Browse by location (623 total)
- Rochester, United States 3 trialsAll trials in Rochester, United States
- Hackensack, United States 3 trialsAll trials in Hackensack, United States
- Dallas, United States 3 trialsAll trials in Dallas, United States
- Louisville, United States 3 trialsAll trials in Louisville, United States
- Orange, United States 2 trialsAll trials in Orange, United States
- Hangzhou, China 2 trialsAll trials in Hangzhou, China
- Gdynia, Poland 2 trialsAll trials in Gdynia, Poland
- Ramat Gan, Israel 2 trialsAll trials in Ramat Gan, Israel
- Detroit, United States 2 trialsAll trials in Detroit, United States
- Zhengzhou, China 2 trialsAll trials in Zhengzhou, China
- Córdoba, Argentina 2 trialsAll trials in Córdoba, Argentina
- Lviv, Ukraine 2 trialsAll trials in Lviv, Ukraine
- Calgary, Canada 2 trialsAll trials in Calgary, Canada
- Honolulu, United States 2 trialsAll trials in Honolulu, United States
- Jacksonville, United States 2 trialsAll trials in Jacksonville, United States
- Dresden, Germany 2 trialsAll trials in Dresden, Germany
- Brescia, Italy 2 trialsAll trials in Brescia, Italy
- Hefei, China 2 trialsAll trials in Hefei, China
- Philadelphia, United States 2 trialsAll trials in Philadelphia, United States
- Houston, United States 2 trialsAll trials in Houston, United States